Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9091 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.9091 |
High Similarity |
NPD5124 |
Phase 1 |
0.8898 |
High Similarity |
NPD422 |
Phase 1 |
0.85 |
High Similarity |
NPD1652 |
Phase 2 |
0.8309 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8309 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8162 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8154 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8082 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8056 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8045 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8029 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7986 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.797 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7933 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7929 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7908 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7902 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7895 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7895 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7881 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7868 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7862 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7852 |
Intermediate Similarity |
NPD920 |
Approved |
0.7847 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7847 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7847 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7847 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7832 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD3748 |
Approved |
0.782 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7801 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7793 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7786 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7742 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7733 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7724 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7708 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7703 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7703 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7698 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7677 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7638 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7626 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7613 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD8651 |
Approved |
0.76 |
Intermediate Similarity |
NPD2532 |
Approved |
0.76 |
Intermediate Similarity |
NPD2534 |
Approved |
0.76 |
Intermediate Similarity |
NPD5401 |
Approved |
0.76 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7591 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7586 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7582 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7571 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7552 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7535 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7535 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7519 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7518 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7483 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7483 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7442 |
Intermediate Similarity |
NPD290 |
Approved |
0.7434 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7429 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7429 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7424 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7417 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7403 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7397 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7397 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7388 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7388 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7383 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7376 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD37 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7362 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD919 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7325 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7323 |
Intermediate Similarity |
NPD940 |
Approved |
0.7323 |
Intermediate Similarity |
NPD846 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7296 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2415 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD447 |
Suspended |
0.726 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.726 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.723 |
Intermediate Similarity |
NPD5588 |
Approved |
0.723 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7229 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7208 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7194 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD6362 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1048 |
Approved |
0.7172 |
Intermediate Similarity |
NPD411 |
Approved |
0.7169 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7169 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7163 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7133 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7115 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7107
|
Intermediate Similarity |
NPD1465 |
Phase 2 |